© 2016 CARBALIVE

  • Twitter Clean
The CARBALIVE project has drawn together a consoritum of experienced and expert research groups within the field of liver disease in order to translate this innovative new approach to therapy from the research laboratory to clinical practice. The research programme will be undertaken by undertaking research and development in the following areas:
  • Regulatory and Ethical Approval for clinical trials
  • Production of clinical grade Yaq-001
  • Clinical trials management
  • Does escalating study for Yaq-001
  • A randomised, double blind, placebo-controlled study in patients with cirrhosis
  • A randomised controlled clincial study in non-alcoholic fatty liver disease patients
  • Biobanking and biomarkers